drugset / Trial / NCT00358748

Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants

NCT00358748

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the early use of hydrocortisone in hypotensive very low birth weight infants. Based on the observations that: * hypotension is a common problem in very low birthweight infants and is associated with brain injury and poor neurological outcomes; * some infants are refractory to standard treatment (volume expansion and vasopressors), which is not exempt of adverse effects; * relative adrenal insufficiency has been described in this population; we hypothesize that hydrocortisone is effective in the treatment of hypotension in this population and reduce the need for vasopressors.

Timeline

Start
2005-07
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 0.5 mg/kg Intravenous

Indications

No indication recorded.